These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
362 related articles for article (PubMed ID: 11319759)
1. Growth inhibition due to complementation of transforming growth factor-beta receptor type II-defect by human chromosome 3 transfer in human colorectal carcinoma cells. Miyafuji Y; Zhong X; Uchida I; Koi M; Hemmi H J Cell Physiol; 2001 Jun; 187(3):356-64. PubMed ID: 11319759 [TBL] [Abstract][Full Text] [Related]
2. Mutational analysis of the transforming growth factor beta receptor type II gene in hereditary nonpolyposis colorectal cancer and early-onset colorectal cancer patients. Shin KH; Park YJ; Park JG Clin Cancer Res; 2000 Feb; 6(2):536-40. PubMed ID: 10690536 [TBL] [Abstract][Full Text] [Related]
3. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1. Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325 [TBL] [Abstract][Full Text] [Related]
4. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells. Jiang W; Tillekeratne MP; Brattain MG; Banerji SS Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753 [TBL] [Abstract][Full Text] [Related]
5. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma. Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633 [TBL] [Abstract][Full Text] [Related]
6. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation. Jakowlew SB; Moody TW; Mariano JM Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635 [TBL] [Abstract][Full Text] [Related]
7. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells. Ye SC; Foster JM; Li W; Liang J; Zborowska E; Venkateswarlu S; Gong J; Brattain MG; Willson JK Cancer Res; 1999 Sep; 59(18):4725-31. PubMed ID: 10493532 [TBL] [Abstract][Full Text] [Related]
8. Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)(2)D(3). Chen A; Davis BH; Sitrin MD; Brasitus TA; Bissonnette M Am J Physiol Gastrointest Liver Physiol; 2002 Oct; 283(4):G864-74. PubMed ID: 12223346 [TBL] [Abstract][Full Text] [Related]
9. Overexpression of transforming growth factor beta type I receptor abolishes malignant phenotype of a rat bladder carcinoma cell line. Okamoto M; Oyasu R Cell Growth Differ; 1997 Aug; 8(8):921-6. PubMed ID: 9269901 [TBL] [Abstract][Full Text] [Related]
10. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III. Deng X; Bellis S; Yan Z; Friedman E Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213 [TBL] [Abstract][Full Text] [Related]
11. Rap1 reverses transcriptional repression of TGF-beta type II receptor by a mechanism involving AP-1 in the human pancreatic cancer cell line, UK Pan-1. Fralix KD; Zhao S; Venkatasubbarao K; Freeman JW J Cell Physiol; 2003 Jan; 194(1):88-99. PubMed ID: 12447993 [TBL] [Abstract][Full Text] [Related]
12. SD-208, a novel transforming growth factor beta receptor I kinase inhibitor, inhibits growth and invasiveness and enhances immunogenicity of murine and human glioma cells in vitro and in vivo. Uhl M; Aulwurm S; Wischhusen J; Weiler M; Ma JY; Almirez R; Mangadu R; Liu YW; Platten M; Herrlinger U; Murphy A; Wong DH; Wick W; Higgins LS; Weller M Cancer Res; 2004 Nov; 64(21):7954-61. PubMed ID: 15520202 [TBL] [Abstract][Full Text] [Related]
13. Soluble type II transforming growth factor-beta (TGF-beta) receptor inhibits TGF-beta signaling in COLO-357 pancreatic cancer cells in vitro and attenuates tumor formation. Rowland-Goldsmith MA; Maruyama H; Kusama T; Ralli S; Korc M Clin Cancer Res; 2001 Sep; 7(9):2931-40. PubMed ID: 11555612 [TBL] [Abstract][Full Text] [Related]
14. Truncation of the TGF-beta type II receptor gene results in insensitivity to TGF-beta in human gastric cancer cells. Yang HK; Kang SH; Kim YS; Won K; Bang YJ; Kim SJ Oncogene; 1999 Apr; 18(13):2213-9. PubMed ID: 10327067 [TBL] [Abstract][Full Text] [Related]
15. Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects. Tobin SW; Douville K; Benbow U; Brinckerhoff CE; Memoli VA; Arrick BA Oncogene; 2002 Jan; 21(1):108-18. PubMed ID: 11791181 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition. Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154 [TBL] [Abstract][Full Text] [Related]
17. Mutation analysis of the transforming growth factor-beta type II receptor in human cell lines resistant to growth inhibition by transforming growth factor-beta. Vincent F; Nagashima M; Takenoshita S; Khan MA; Gemma A; Hagiwara K; Bennett WP Oncogene; 1997 Jul; 15(1):117-22. PubMed ID: 9233784 [TBL] [Abstract][Full Text] [Related]
18. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer. Kang SH; Bang YJ; Im YH; Yang HK; Lee DA; Lee HY; Lee HS; Kim NK; Kim SJ Oncogene; 1999 Dec; 18(51):7280-6. PubMed ID: 10602482 [TBL] [Abstract][Full Text] [Related]
19. Mutations of transforming growth factor beta 1 type II receptor, BAX, and insulin-like growth factor II receptor genes in microsatellite unstable cell lines. Carethers JM; Pham TT In Vivo; 2000; 14(1):13-20. PubMed ID: 10757056 [TBL] [Abstract][Full Text] [Related]
20. Differential control of expression of type I and type II receptors of transforming growth factor-beta in colon carcinoma cells. Periyasamy S; Sun L; Gentry LE; Brattain MG J Cell Physiol; 1996 Sep; 168(3):711-20. PubMed ID: 8816926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]